©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 110202
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.110202
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.110202
Table 2 Expression of KLK5 in some types of cancer
| Cancer | Expression of KLK5 in the tumor compared with non-tumor conditions | Ref. |
| Breast cancer | Expression depends on stage, grade, and metastasis | [65,66,70,74] |
| Oral squamous cell carcinoma | Expression depends on stage, grade, and metastasis | [88,89,97] |
| Vaginal carcinogenesis | Decreased | [34] |
| Prostate cancer | Decreased | [35] |
| Testicular cancer | Decreased | [67] |
| Ovarian cancer | Increased | [77,68] |
| Skin tumorigenesis | Increased | [61] |
| Urinary bladder carcinoma cells | Increased | [84] |
| Uterine cervical cancer | Increased | [76] |
| Lung cancer | Increased | [83] |
| Gastric adenocarcinoma | Increased | [81] |
- Citation: Palacios Serrato EG, Medina-Abreu KH, Oropeza-Martínez E, Jacinto-Alemán LF, Macías-Silva M, Tecalco-Cruz AC. ADAMTS-8 and kallikrein-related peptidases 10 and 5 proteases also have a tumor suppression role. World J Clin Oncol 2025; 16(11): 110202
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/110202.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.110202